ABSTRACT

Clinical stage I nonseminomatous germ cell tumors can be approached by several successful treatment strategies.

Surveillance, primary chemotherapy, and open retroperitoneal lymph node dissection all demonstrate equivalent outcomes when applied appropriately. As such, morbidity of the treatment becomes the major factor when selecting treatment.